Cardiocore, a cardiac testing laboratory, will now offer centralized echocardiographic analyses, which the company said can support the growing needs of oncology and cardiovascular clinicians, as well as drug developers who use echocardiography to study cardiac safety and efficacy.

The Bethesda, Md.-based Cardiocore reported that its echocardiography analyses include ejection fraction, ejection time, cardiac output, fractional shortening, left ventricular volumes, left ventricular mass, and various Doppler, 2D and M-Mode calculations.